- Home
- UTF vs RXRX Comparison
UTF vs RXRX Comparison
Compare UTF & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTF
- RXRX
- Stock Information
- Founded
- UTF 2004
- RXRX 2013
- Country
- UTF United States
- RXRX United States
- Employees
- UTF N/A
- RXRX N/A
- Industry
- UTF Finance Companies
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- UTF Finance
- RXRX Health Care
- Exchange
- UTF Nasdaq
- RXRX Nasdaq
- Market Cap
- UTF 2.4B
- RXRX 2.4B
- IPO Year
- UTF N/A
- RXRX 2021
- Fundamental
- Price
- UTF $24.75
- RXRX $4.71
- Analyst Decision
- UTF
- RXRX Buy
- Analyst Count
- UTF 0
- RXRX 4
- Target Price
- UTF N/A
- RXRX $7.25
- AVG Volume (30 Days)
- UTF 171.7K
- RXRX 17.0M
- Earning Date
- UTF 01-01-0001
- RXRX 11-05-2025
- Dividend Yield
- UTF 7.19%
- RXRX N/A
- EPS Growth
- UTF N/A
- RXRX N/A
- EPS
- UTF 2.84
- RXRX N/A
- Revenue
- UTF $138,636,669.00
- RXRX $64,596,000.00
- Revenue This Year
- UTF N/A
- RXRX $24.09
- Revenue Next Year
- UTF N/A
- RXRX $20.99
- P/E Ratio
- UTF $9.16
- RXRX N/A
- Revenue Growth
- UTF 19.80
- RXRX 30.14
- 52 Week Low
- UTF $22.05
- RXRX $3.79
- 52 Week High
- UTF $26.53
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- UTF 23.10
- RXRX 42.97
- Support Level
- UTF $24.52
- RXRX $4.51
- Resistance Level
- UTF $26.17
- RXRX $5.09
- Average True Range (ATR)
- UTF 0.31
- RXRX 0.26
- MACD
- UTF -0.18
- RXRX 0.04
- Stochastic Oscillator
- UTF 10.31
- RXRX 40.63
About UTF Cohen & Steers Infrastructure Fund Inc
Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.